Dr. Lal was working on a ceramic coating before joining ZBH in 2018. Maybe he is in Swindon? In addition to reducing the EM amplification effect, ceramic coatings also reduce the amount of titanium in the blood by reducing corrosion. But again the coating needs to be the right ceramic thats more biologically compatible. Dr. Lal was working with one such substance when he was involved with Life Long Joints projects.
https://www.nature.com/articles/s41598-018-27494-y
Biological Impact of Silicon Nitride for Orthopaedic Applications: Role of Particle Size, Surface Composition and Donor Variation
Saurabh Lal
https://www.nature.com/articles/s41598-018-27494-y
Could it be that there is a strategy to distract people away from looking at the basic data?
Is all this an exercise to create more and more forum verbiage to drown out any serious discussion of evidence?
Recent ZBH News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/27/2026 09:30:16 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/27/2026 09:00:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 08:14:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 08:13:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 08:12:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 08:12:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 08:11:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 08:10:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 08:10:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 08:09:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 08:08:32 PM
- Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026 • PR Newswire (US) • 05/22/2026 08:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/19/2026 07:19:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/12/2026 06:47:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 10:30:17 AM
- Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year End • PR Newswire (US) • 05/12/2026 10:30:00 AM
- Zimmer Biomet to Present at the BofA Securities 2026 Health Care Conference • PR Newswire (US) • 05/06/2026 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2026 08:08:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/01/2026 09:11:37 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/30/2026 06:48:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 10:33:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 10:30:16 AM
- Zimmer Biomet Announces First Quarter 2026 Financial Results • PR Newswire (US) • 04/28/2026 10:30:00 AM
- Zimmer Biomet Announces Chief Financial Officer Transition • PR Newswire (US) • 04/28/2026 10:29:00 AM
- Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results • PR Newswire (US) • 04/09/2026 11:30:00 AM
